Displaying publications 21 - 40 of 22694 in total

Abstract:
Sort:
  1. Majeed AR
    Med J Malaysia, 1978 Dec;33(2):146-8.
    PMID: 755166
    Matched MeSH terms: Male
  2. Sankararaman H, Manickavasagam S, Triapitsyn SV, Huber JT, Kharbisnop B
    Zootaxa, 2020 Oct 27;4868(2):zootaxa.4868.2.4.
    PMID: 33311400 DOI: 10.11646/zootaxa.4868.2.4
    An overview of the Oriental species of the nominate subgenus of Camptopteroides Viggiani (Hymenoptera: Mymaridae) is given. Two new species, C. (Camptopteroides) formosa Manickavasagam Sankararaman sp. n. from India and C. (Camptopteroides) reducta Triapitsyn sp. n. from Thailand and Malaysia, are described, and C. formosa additionally compared to two unnamed species. The holotype male of the type species of this genus, C. armata Viggiani from Sri Lanka, is diagnosed and illustrated. A key to Old World species of Camptopteroides is provided.
    Matched MeSH terms: Male
  3. Galloway D
    Malayan Medical Journal, 1933;8:129-33.
    Matched MeSH terms: Male
  4. Kakizoe S, Maruyama M, Masumoto K
    Zookeys, 2019.
    PMID: 30814901 DOI: 10.3897/zookeys.824.31627
    Cheleionwatanabeisp. n. is described from Pahang, Peninsular Malaysia and represents the third species of the genus Cheleion Vårdal & Forshage, 2010 (Coleoptera, Scarabaeidae, Aphodiinae, Stereomerini). A description of the previously unknown male of C.jendeki Král & Hájek, 2015, and a key to the species of the genus Cheleion are also provided.
    Matched MeSH terms: Male
  5. Ganeson SK, Saniasiaya J, Mohamad I, Abdul Gani N
    Gulf J Oncolog, 2020 Sep;1(34):83-86.
    PMID: 33431368
    INTRODUCTION: Basaloid squamous cell carcinoma of the nasopharynx is a rare entity with only scarce cases reported in the English Literature. It is a histological variant of squamous cell carcinoma with aggressive nature and comprises of both basal cell carcinoma and squamous cell carcinoma.

    CASE PRESENTATION: Herein, we report on a middleaged male who presented with left-sided spontaneous epistaxis and aural fullness with no neck node which turned out to be basaloid cell carcinoma of nasopharynx.

    DISCUSSION AND CONCLUSION: We highlight high clinical suspicion of rare variant of nasopharyngeal carcinoma although no palpable node was evident upon presentation.

    Matched MeSH terms: Male
  6. Ko E, Ramasamy R, Durairajanayagam D, Baskaran S, Agarwal A
    Andrologia, 2021 02;53(1):e13741.
    PMID: 33135797 DOI: 10.1111/and.13741
    Matched MeSH terms: Male
  7. Kew-kim C
    Med J Malaya, 1969 Jun;23(4):256-9.
    PMID: 4242171
    Matched MeSH terms: Male
  8. ORAM TF
    Med J Malaya, 1954 Jun;8(4):337-42.
    PMID: 13193271
    Matched MeSH terms: Male
  9. Rajapaksa AC, Kwee NK
    Med J Malaysia, 1976 Sep;31(1):73-4.
    PMID: 1023018
    Matched MeSH terms: Male
  10. Brooke GE
    Lancet, 1916;188:18.
    DOI: 10.1016/S0140-6736(01)26402-2
    Matched MeSH terms: Male
  11. Nelson VK, Pullaiah CP, Saleem Ts M, Roychoudhury S, Chinnappan S, Vishnusai B, et al.
    Adv Exp Med Biol, 2022;1391:161-179.
    PMID: 36472822 DOI: 10.1007/978-3-031-12966-7_10
    Prostate cancer is the most commonly diagnosed and frequently occurred cancer in the males globally. The current treatment strategies available to treat prostate cancer are not much effective and express various adverse effects. Hence, there is an urgent need to identify novel treatment that can improve patient outcome. From times immemorial, natural products are highly recognized for novel drug development for various diseases including cancer. Cancer cells generally maintain higher basal levels of reactive oxygen species (ROS) when compared to normal cells due to its high metabolic rate. However, initiation of excess intracellular ROS production can not be tolerated by the cancer cells and induce several cell death signals which are in contrast to normal cells. Therefore, small molecules of natural origin that induce ROS can potentially kill cancer cells in specific and provide a better opportunity to develop a novel drug therapy. In this review, we elaborated various classes of medicinal compounds and their mechanism of killing prostate cancer cells through direct or indirect ROS generation. This can generate a novel thought to develop promising drug candidate to treat prostate cancer patients.
    Matched MeSH terms: Male
  12. Saeidi H, Raju CS, Ismail P, Raub SHA, Omar N, Hisyam Bakrin I
    Cell Mol Biol (Noisy-le-grand), 2022 Aug 31;68(8):22-26.
    PMID: 36800845 DOI: 10.14715/cmb/2022.68.8.4
    Genetic alterations in the homologous recombination repair (HRR) genes are associated with an increased risk of prostate cancer development, and patients harboring these mutations can benefit from targeted therapy. The main aim of this study is to identify genetic alterations in HRR genes as a potential target for targeted treatment. In this study, targeted next generation sequencing (NGS) is used to analyze mutations in the protein-coding regions of the 27 genes involved in HRR and mutations in hotspots of 5 cancer-associated genes in four FFPE samples and three blood samples from prostate cancer patients. We identified two mutations in TP53 and KRAS. We also identified four conflicting interpretations of pathogenicity variants in BRCA2, STK11 genes and one variant of uncertain significance in the RAD51B gene. In addition, we detected one drug response variant in TP53, and two novel variants in CDK12 and ATM. Our results revealed some actionable pathogenic and potential pathogenic variants that may be associated with response to the Poly (ADP-ribose) polymerase (PARP) inhibitor treatment. More studies in a larger cohort are needed to evaluate and determine the association of HRR mutations with prostate cancer.
    Matched MeSH terms: Male
  13. Basil Peter A, Lohshini Kanoo L, Abd Malek K, Mohd Razalli M
    Aust J Gen Pract, 2023 Oct;52(10):701-703.
    PMID: 37788689 DOI: 10.31128/AJGP-08-22-6545
    Matched MeSH terms: Male
  14. Tan D, Mohd Nasir NF, Abdul Manan H, Yahya N
    Cancer Radiother, 2023 Sep;27(5):398-406.
    PMID: 37482464 DOI: 10.1016/j.canrad.2023.05.001
    PURPOSE: This study aims to perform a comprehensive systematic review of deep learning (DL) models in predicting RT-induced toxicity.

    MATERIALS AND METHODS: A literature review was performed following the PRISMA guidelines. Systematic searches were performed in PubMed, Scopus, Cochrane and Embase databases from the earliest record up to September 2022. Related studies on deep learning models for radiotherapy toxicity prediction were selected based on predefined PICOS criteria.

    RESULTS: Fourteen studies of radiotherapy-treated patients on different types of cancer [prostate (n=2), HNC (n=4), liver (n=2), lung (n=4), cervical (n=1), and oesophagus (n=1)] were eligible for inclusion in the systematic review. Information regarding patient characteristics and model development was summarized. Several approaches, such as ensemble learning, data augmentation, and transfer learning, that were utilized by selected studies were discussed.

    CONCLUSION: Deep learning techniques are able to produce a consistent performance for toxicity prediction. Future research using large and diverse datasets and standardization of the study methodologies are required to improve the consistency of the research output.

    Matched MeSH terms: Male
  15. Zhang C, Zhao JJ, Martens J
    Zootaxa, 2023 Sep 26;5351(2):276-286.
    PMID: 38221489 DOI: 10.11646/zootaxa.5351.2.5
    Tegestria altmannae sp. nov. is described and illustrated based on male and female specimens collected in Malaysia. It is characterized by the unarmed dorsal scutum, and basal segment of chelicerae dorsally with three seta-tipped tubercles. The type species of the monotypic genus Gintingius Roewer, 1938, G. robustus Roewer, 1938, is treated as a new synonym of Tegestria coniata Roewer, 1938 and the genus Gintingius as a new synonym of Tegestria Roewer, 1936, accordingly.
    Matched MeSH terms: Female; Male
  16. Tan WK, Tan MY, Tan WS, Gan SC, Pathmanathan R, Tan HM, et al.
    Clin Genitourin Cancer, 2016 Aug;14(4):e435-9.
    PMID: 27067374 DOI: 10.1016/j.clgc.2016.03.007
    Matched MeSH terms: Male
  17. Farook F, Al Meshrafi A, Mohamed Nizam N, Al Shammari A
    Am J Mens Health, 2021;15(3):15579883211007277.
    PMID: 34013796 DOI: 10.1177/15579883211007277
    The objective of this study is to investigate the association between periodontitis (PD) and erectile dysfunction (ED).A systematic review and meta-analysis on data was extracted and conducted according to PRISMA. Relevant articles were selected from a literature search using MEDLINE, EMBASE, Scopus, Web of Science and CENTRAL from inception until August 2, 2020. Both randomized and nonrandomized controlled studies were included. Case reports, case series, nonsystematic reviews and trials published as abstract were excluded. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to estimate the association between PD and the risk of ED. The meta-analysis was conducted with RevMan 5.3. Methodological quality assessment was carried out using the Newcastle-Ottawa Quality Assessment Scale and the quality of evidence was assessed using the GRADE approach.Six articles (215008 subjects) were included for analysis. Of the participants, 38,675 cases were compared to 1,76,333 healthy controls. Based on the random effects model, periodontitis was associated with an increased risk of ED (OR = 2.56, 95% CI: 1.70-3.85) as compared with the non-periodontitis individuals. The findings were statistically significant with a p < .0001. The statistical heterogeneity was high across all studies (I2 = 98%, p < .00001). Estimates of total effects were generally consistent with the sensitivity and subgroup analyses.Within the limits of the available evidence, our review and meta-analysis showed that a significant association exists between the PD and ED. The results should be interpreted with caution due to high degree of inconsistency across all the studies.
    Matched MeSH terms: Male
  18. Zainudin MF, Hasim MR, Martin CE, Chandrabose T
    Spinal Cord Ser Cases, 2024 Apr 25;10(1):30.
    PMID: 38664389 DOI: 10.1038/s41394-024-00642-5
    INTRODUCTION: Acute transverse myelitis (ATM) is a rare neurological complication of Coronavirus disease (COVID-19) vaccines. Various vaccines have been linked to ATM, such as non-replicating viral vectors, ribonucleic acid, and inactivated vaccines. An ATM case is presented here involving the BNT162b2 vaccine leading to asymmetrical incomplete paraplegia and neurogenic bladder.

    CASE PRESENTATION: A 66-year-old male developed urinary retention one day after his second dose of the BNT162b2 vaccine, followed by rapidly progressing lower limb weakness. Clinical examination showed asymmetrical paraparesis, reduced sensation below the T8 level, including perianal sensation, and loss of ankle and anal reflexes. Laboratory tests were largely unremarkable, while the spine MRI revealed thickened conus medullaris with a mild increase in T2/STIR signal intensity and subtle enhancement post gadolinium. Following treatment with methylprednisolone, plasmapheresis, and immunoglobulin, and a rehabilitation program, the patient achieved good motor and sensory recovery, but the bladder dysfunction persisted. Single-channel cystometry indicated neurogenic detrusor underactivity and reduced bladder sensation, as evidenced by low-pressure and compliant bladder. The urethral sphincter appeared intact or overactive. The post-void residual urine was significant, necessitating prolonged intermittent catheterisation.

    DISCUSSION: Bladder dysfunction due to the COVID-19 vaccine-associated ATM is not as commonly reported as motor or sensory deficits. To our knowledge, this is the first case to highlight a neurogenic bladder that necessitates prolonged intermittent catheterisation as a consequence of COVID-19 vaccine-associated ATM. This report highlights the rare complication of the neurogenic bladder resulting from the BNT162b2 vaccine. Early detection and treatment are crucial to prevent long-term complications.

    Matched MeSH terms: Male
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links